Metraipolis › archive › dc_514f79398afd

Activity of cefiderocol against Pseudomonas aeruginosa from the USA and Europe (2020-2023) with difficult-to-treat resistance phenotype, including those… — Europe PMC PMID:41081390

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41081390
DOI
10.1128/spectrum.02079-25
License (as archived)
solo-consultazione
Archived
2026-11-09T08:44:25.402Z
SHA-256 of the archived text
eb2252520269e484a39bba9bde0b4262cb20a990b28968c615c6b4dd8a5c2bd5
Stable URL of this page
https://metraipolis.com/documento/dc_514f79398afd

How to cite

Activity of cefiderocol against Pseudomonas aeruginosa from the USA and Europe (2020-2023) with difficult-to-treat resistance phenotype, including those… — Europe PMC PMID:41081390 — Europe PMC (en), https://europepmc.org/article/MED/41081390 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_514f79398afd (Metraipolis archive dc_514f79398afd, sha256 eb2252520269e484a39bba9bde0b4262cb20a990b28968c615c6b4dd8a5c2bd5)
BibTeX
@misc{dc514f79398afd,
  title = {Activity of cefiderocol against Pseudomonas aeruginosa from the USA and Europe (2020-2023) with difficult-to-treat resistance phenotype, including those… — Europe PMC PMID:41081390},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41081390},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_514f79398afd; sha256 eb2252520269e484a39bba9bde0b4262cb20a990b28968c615c6b4dd8a5c2bd5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41081390. Agents can read the archived copy with the MCP tool read_document.